Development of a pharmacodynamic biomarker to measure target engagement from inhibition of the NGF-TrkA pathway
Keywords: NGF (عامل رشد عصب); TrkA (tropomyosin receptor kinase); NGF (nerve growth factor); Pharmacodynamic biomarker; Rodent pain model; Neurotrophin; Enzyme-linked immunosorbent assays (ELISAs);